The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

16 articles for X Jiao


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.EBI
Amgen
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists.EBI
Amgen
Aminopyrazole-Phenylalanine Based GPR142 Agonists: Discovery of Tool Compound and in Vivo Efficacy Studies.EBI
Amgen
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles.EBI
Amgen
Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors.EBI
Amgen
Structure-based design of novel inhibitors of the MDM2-p53 interaction.EBI
Amgen
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist.EBI
TBA
Discovery and optimization of a series of liver X receptor antagonists.EBI
Amgen
The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators.EBI
Amgen
Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors.EBI
Amgen
Synthesis and biological evaluation of new series of quinazoline derivatives as EGFR/HER2 dual-target inhibitors.EBI
Jiangnan University
Synthesis and biological evaluation of diaryl urea derivatives as FLT3 inhibitors.EBI
Jiangnan University
5-Alkyl-2-urea-Substituted Pyridines: Identification of Efficacious Glucokinase Activators with Improved Properties.EBI
Amgen
Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman Primates.EBI
Amgen Discovery Research
Discovery of a Highly Selective STK16 Kinase Inhibitor.BDB
Chinese Academy of Sciences
Inhibition of arginine aminopeptidase by bestatin and arphamenine analogues. Evidence for a new mode of binding to aminopeptidases.BDB
University of Wisconsin